Boston Marriott Long Wharf, 296 State St, Boston, MA, 02109
Date: October 14-15, 2024
Location: Boston Marriott Long Wharf
Price: $2,150 USD (early registration discount of $1,800 USD ends Sunday, September 1, 2024)
The release of ISO 10993-1:2018, 10993-18:2020 and the Medical Device Regulation (MDR) General Safety and Performance Requirements (GSPR) bring several challenges for medical device manufacturers. The industry is experiencing the most drastic updates in the biological evaluation of medical devices since the issuance of the ISO 10993 standards.
This course is structured to tackle each of these challenges and provide hands-on experiential learning. It is designed for those who require a working knowledge of biocompatibility or are looking to update and sharpen their skills. Participants can expect to learn how to use standards to establish a biological safety evaluation plan, as well as how to document and implement their plan. Use of material/chemical characterization and risk assessment will be highlighted, as will real-world exercises to practice evaluating biological risk. (In order to be certified as a Biological Safety Specialist, participants must attend and complete all exercises over the 2-day course).
Course Objectives
Upon course completion, attendees will be able to:
September 14-17, 2024 $3,650 USD (early registration discount of $2,950 USD ends Sunday, September 1, 2024)
NOTE: Our security measures require that your credit card billing address match your profile address.
Prerequisite: Course A: Biocompatibility of Medical Devices – Two-Day Certification
Date: October 16-17, 2024
Location: Boston Marriott Long Wharf
Price: $2,150 USD (early registration discount of $1,800 USD ends Sunday, September 1, 2024)
This two-day training course is designed for those who have received certification to the NAMSA Training Series Biocompatibility of Medical Devices – Two-Day Certification Course. Objectives of this course include practice beyond the basics of Table A.1 in ISO 10993, with increased practical application and updated workshops. In addition to traditional medical devices, we will address combination products and resorbable materials. Participants will not only learn how to assess their device for biological risks, but also understand when testing is not necessary.
Utilizing ISO 10993-17, attendees will actively calculate toxicological thresholds with practical chemical characterization data. Additionally, instructors will provide an opportunity to work with real-world medical device case studies and provide solutions and an understanding of how to present data in a submission during the hands-on workshops. Participants will walk away with the knowledge of how to plan a strategy to endure potential obstacles.
Course Objectives
Upon course completion, attendees will be able to:
October 14-17, 2024 $3,650 USD (early registration discount of $2,950 USD ends Sunday, September 1, 2024
NOTE: Our security measures require that your credit card billing address match your profile address.
*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.
NAMSA has secured a limited number of sleeping rooms at the Boston Marriott Long Wharf. Individual reservations can be made by visiting this page.